Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Pulling in cash fast is possible with the right strategies. Learn effective methods to boost your income quickly.
21,139 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Tesla is signaling a profitability-focused future with autonomy and robotics, while BYD drives volume with affordable...
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
Investors are rethinking income strategies as inflation pressures linger and long-term payout growth demonstrates gre...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
Apple rides a fresh all-time high as HSBC analysts turn bullish, lifting targets and signaling more upside. Services ...
Early-season Vail Resorts skier visits slipped about 20%, yet a major investor is stepping in with a multihundred-mil...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...
Investors awakened to a rough start for cruise stocks as Norwegian Cruise Line Holdings shares slid. This piece break...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
Ford faced a massive quarterly loss tied to EV charges, while Winnebago posted a surprise profit swing on premium mot...